141 related articles for article (PubMed ID: 27568125)
1. Effectiveness of the multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) for diabetic microvascular complications: A population-based cohort study.
Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL
Diabetes Metab; 2016 Dec; 42(6):424-432. PubMed ID: 27568125
[TBL] [Abstract][Full Text] [Related]
2. Long-term effects of the multidisciplinary risk assessment and management program for patients with diabetes mellitus (RAMP-DM): a population-based cohort study.
Jiao F; Fung CS; Wan YF; McGhee SM; Wong CK; Dai D; Kwok R; Lam CL
Cardiovasc Diabetol; 2015 Aug; 14():105. PubMed ID: 26268736
[TBL] [Abstract][Full Text] [Related]
3. Ten-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Macrovascular and Microvascular Complications and All-Cause Mortality: A Population-Based Cohort Study.
Tang EHM; Mak IL; Tse ETY; Wan EYF; Yu EYT; Chen JY; Chin WY; Chao DVK; Tsui WWS; Ha TKH; Wong CKH; Lam CLK
Diabetes Care; 2022 Dec; 45(12):2871-2882. PubMed ID: 35972235
[TBL] [Abstract][Full Text] [Related]
4. Five-Year Effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on Diabetes-Related Complications and Health Service Uses-A Population-Based and Propensity-Matched Cohort Study.
Wan EYF; Fung CSC; Jiao FF; Yu EYT; Chin WY; Fong DYT; Wong CKH; Chan AKC; Chan KHY; Kwok RLP; Lam CLK
Diabetes Care; 2018 Jan; 41(1):49-59. PubMed ID: 29138274
[TBL] [Abstract][Full Text] [Related]
5. Five-Year Cost-effectiveness of the Multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM).
Jiao FF; Fung CSC; Wan EYF; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
Diabetes Care; 2018 Feb; 41(2):250-257. PubMed ID: 29246949
[TBL] [Abstract][Full Text] [Related]
6. Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.
O'Brien R; Johnson E; Haneuse S; Coleman KJ; O'Connor PJ; Fisher DP; Sidney S; Bogart A; Theis MK; Anau J; Schroeder EB; Arterburn D
Ann Intern Med; 2018 Sep; 169(5):300-310. PubMed ID: 30083761
[TBL] [Abstract][Full Text] [Related]
7. Effects of the Multidisciplinary Risk Assessment and Management Program for Patients with Diabetes Mellitus (RAMP-DM) on biomedical outcomes, observed cardiovascular events and cardiovascular risks in primary care: a longitudinal comparative study.
Jiao FF; Fung CS; Wong CK; Wan YF; Dai D; Kwok R; Lam CL
Cardiovasc Diabetol; 2014 Aug; 13():127. PubMed ID: 25142791
[TBL] [Abstract][Full Text] [Related]
8. Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial.
Ali MK; Singh K; Kondal D; Devarajan R; Patel SA; Menon VU; Varthakavi PK; Vishwanathan V; Dharmalingam M; Bantwal G; Sahay RK; Masood MQ; Khadgawat R; Desai A; Prabhakaran D; Narayan KMV; Tandon N
PLoS Med; 2024 Jun; 21(6):e1004335. PubMed ID: 38829880
[TBL] [Abstract][Full Text] [Related]
9. Walking pace and microvascular complications among individuals with type 2 diabetes: A cohort study from the UK Biobank.
Zhu X; Zhang X; Zhou C; Li B; Huang Y; Li C; Gu C; Ma M; Zhao S; Fan Y; Xu X; Chang J; Chen H; Zheng Z
Scand J Med Sci Sports; 2024 Jan; 34(1):e14501. PubMed ID: 37740713
[TBL] [Abstract][Full Text] [Related]
10. Risk of Dementia Among Patients With Diabetes in a Multidisciplinary, Primary Care Management Program.
Wang K; Zhao S; Lee EK; Yau SZ; Wu Y; Hung CT; Yeoh EK
JAMA Netw Open; 2024 Feb; 7(2):e2355733. PubMed ID: 38345817
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of a primary care multidisciplinary Risk Assessment and Management Program for patients with diabetes mellitus (RAMP-DM) over lifetime.
Jiao F; Wan EYF; Fung CSC; Chan AKC; McGhee SM; Kwok RLP; Lam CLK
Endocrine; 2019 Feb; 63(2):259-269. PubMed ID: 30155847
[TBL] [Abstract][Full Text] [Related]
12. Diabetic Retinopathy in Patients with Dyslipidemia: Development and Progression.
Jeng CJ; Hsieh YT; Yang CM; Yang CH; Lin CL; Wang IJ
Ophthalmol Retina; 2018 Jan; 2(1):38-45. PubMed ID: 31047300
[TBL] [Abstract][Full Text] [Related]
13. A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy.
Vujosevic S; Pucci P; Casciano M; Daniele A; Bini S; Berton M; Cavarzeran F; Avogaro A; Lapolla A; Midena E
J Diabetes Complications; 2017 Aug; 31(8):1348-1353. PubMed ID: 28551296
[TBL] [Abstract][Full Text] [Related]
14. BMI and BMI change following incident type 2 diabetes and risk of microvascular and macrovascular complications: the EPIC-Potsdam study.
Polemiti E; Baudry J; Kuxhaus O; Jäger S; Bergmann MM; Weikert C; Schulze MB
Diabetologia; 2021 Apr; 64(4):814-825. PubMed ID: 33452586
[TBL] [Abstract][Full Text] [Related]
15. Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: A nationwide cohort study.
Chou AY; Liu CJ; Chao TF; Wang KL; Tuan TC; Chen TJ; Chen SA
Medicine (Baltimore); 2016 Jul; 95(27):e3992. PubMed ID: 27399075
[TBL] [Abstract][Full Text] [Related]
16. Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort.
Cai YW; Zhang HF; Gao JW; Cai ZX; Cai JW; Gao QY; Chen ZT; Liao GH; Zeng CR; Chen N; Liu PM; Wang JF; Chen YX
Diabetes Metab; 2023 Sep; 49(5):101472. PubMed ID: 37678759
[TBL] [Abstract][Full Text] [Related]
17. Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus.
Gao S; Zhang H; Long C; Xing Z
Front Endocrinol (Lausanne); 2021; 12():719515. PubMed ID: 34764938
[TBL] [Abstract][Full Text] [Related]
18. Predictors of development and progression of microvascular complications in a cohort of Brazilian type 2 diabetic patients.
Cardoso CR; Salles GF
J Diabetes Complications; 2008; 22(3):164-70. PubMed ID: 18413219
[TBL] [Abstract][Full Text] [Related]
19. Macrovascular and microvascular disease in obese patients with type 2 diabetes attending structured diabetes education program: a population-based propensity-matched cohort analysis of Patient Empowerment Programme (PEP).
Wong CK; Wong WC; Wan EY; Chan AK; Chan FW; Lam CL
Endocrine; 2016 Aug; 53(2):412-22. PubMed ID: 26785847
[TBL] [Abstract][Full Text] [Related]
20. Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133).
Pradeepa R; Surendar J; Indulekha K; Chella S; Anjana RM; Mohan V
Clin Biochem; 2015 Jan; 48(1-2):33-8. PubMed ID: 25445230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
